Literature DB >> 1924145

Insulin aggregation in aqueous media and its effect on alpha-chymotrypsin-mediated proteolytic degradation.

F Y Liu1, D O Kildsig, A K Mitra.   

Abstract

Self-association of zinc-insulin monomers into dimers and hexamers may lead to enhanced protection of the peptide from proteolytic degradation. The present study has been undertaken to investigate the relationship, if any, between the rate of enzymatic degradation of insulin by a protease, alpha-chymotrypsin, and the extent of insulin aggregation in aqueous solutions. Insulin solutions (0.6 mg/ml) containing varying proportions of dimer and hexamer were obtained by adding ethylene diamine tetraacetic acid (EDTA) within a concentration range of 0.005 to 0.040 mM. As the EDTA concentration was increased above 0.040 mM, a complete dissociation of hexamers to dimers occurred and the rate of enzymatic degradation reached its maximum. The overall first-order rate constants appeared to be linearly related to the square of EDTA concentrations. The apparent first-order rate constants for dimer and hexamer degradation obtained from a linear plot of rate constant versus EDTA squared concentration were found to be 0.02800 +/- 0.00065 and 0.00798 +/- 0.00075 min-1, respectively. Two major insulin degradation products were also detected and the kinetics of product appearance agreed well with the disappearance kinetics of insulin. The results indicated that the degradation of insulin dimers by alpha-chymotrypsin is about 3.5 times faster than the degradation of the hexamer. The second-order dependency of degradation rate on EDTA concentration might be due to the fact that insulin hexamers contain two zinc ions which are sequestered by two EDTA molecules. Chelation of zinc ions by EDTA lead to hexamer deaggregation to dimers as was evidenced from a circular dichroism study.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1924145     DOI: 10.1023/a:1015820032648

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  7 in total

1.  Degradation of insulin by trypsin and alpha-chymotrypsin.

Authors:  R J Schilling; A K Mitra
Journal:  Pharm Res       Date:  1991-06       Impact factor: 4.200

2.  Modeling absorption kinetics of subcutaneous injected soluble insulin.

Authors:  E Mosekilde; K S Jensen; C Binder; S Pramming; B Thorsteinsson
Journal:  J Pharmacokinet Biopharm       Date:  1989-02

3.  Zinc binding, circular dichroism, and equilibrium sedimentation studies on insulin (bovine) and several of its derivatives.

Authors:  J Goldman; F H Carpenter
Journal:  Biochemistry       Date:  1974-10-22       Impact factor: 3.162

4.  Prevention of insulin self-association and surface adsorption.

Authors:  S Sato; C D Ebert; S W Kim
Journal:  J Pharm Sci       Date:  1983-03       Impact factor: 3.534

5.  The effect of zinc on insulin metabolism.

Authors:  E R Arquilla; S Packer; W Tarmas; S Miyamoto
Journal:  Endocrinology       Date:  1978-10       Impact factor: 4.736

6.  Minimizing the aggregation of neutral insulin solutions.

Authors:  R Quinn; J D Andrade
Journal:  J Pharm Sci       Date:  1983-12       Impact factor: 3.534

7.  Nonaggregating insulin solutions for long-term glucose control in experimental and human diabetes.

Authors:  A M Albisser; W Lougheed; K Perlman; A Bahoric
Journal:  Diabetes       Date:  1980-03       Impact factor: 9.461

  7 in total
  11 in total

1.  Inhibition of insulin fibrillogenesis with targeted peptides.

Authors:  Todd J Gibson; Regina M Murphy
Journal:  Protein Sci       Date:  2006-04-05       Impact factor: 6.725

2.  Chemical and alpha-chymotrypsin-mediated proteolytic degradation of insulin in bile salt-unsaturated fatty acid mixed micellar systems.

Authors:  Y Li; Z Shao; A K Mitra
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

3.  Chemically Precise Glycoengineering Improves Human Insulin.

Authors:  Xiaoyang Guan; Patrick K Chaffey; Xiuli Wei; Daniel R Gulbranson; Yuan Ruan; Xinfeng Wang; Yaohao Li; Yan Ouyang; Liqun Chen; Chen Zeng; Theo N Koelsch; Amy H Tran; Wei Liang; Jingshi Shen; Zhongping Tan
Journal:  ACS Chem Biol       Date:  2017-12-01       Impact factor: 5.100

4.  Insulin nanoparticles: a novel formulation approach for poorly water soluble Zn-insulin.

Authors:  Elaine Merisko-Liversidge; Simon L McGurk; Gary G Liversidge
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

5.  Insulin self-association: effects on lung disposition kinetics in the airways of the isolated perfused rat lung (IPRL).

Authors:  Yinuo Pang; Masahiro Sakagami; Peter R Byron
Journal:  Pharm Res       Date:  2007-05-03       Impact factor: 4.200

6.  Stability of acyl derivatives of insulin in the small intestine: relative importance of insulin association characteristics in aqueous solution.

Authors:  H Asada; T Douen; Y Mizokoshi; T Fujita; M Murakami; A Yamamoto; S Muranishi
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

7.  Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations.

Authors:  Z Shao; R Krishnamoorthy; A K Mitra
Journal:  Pharm Res       Date:  1992-09       Impact factor: 4.200

8.  Differential effects of anionic, cationic, nonionic, and physiologic surfactants on the dissociation, alpha-chymotryptic degradation, and enteral absorption of insulin hexamers.

Authors:  Z Shao; Y Li; R Krishnamoorthy; T Chermak; A K Mitra
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

9.  Dissociation of insulin oligomers by bile salt micelles and its effect on alpha-chymotrypsin-mediated proteolytic degradation.

Authors:  Y Li; Z Shao; A K Mitra
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

Review 10.  Zinc transporters and their role in the pancreatic β-cell.

Authors:  Katleen Lemaire; Fabrice Chimienti; Frans Schuit
Journal:  J Diabetes Investig       Date:  2012-06-06       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.